Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Miles D White. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Miles D White har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:CAT / Caterpillar Inc. | Director | 8 382 |
US:MCD / McDonald's Corporation | Director | 18 613 |
US:ABT / Abbott Laboratories | EXECUTIVE CHAIRMAN, Director | 3 092 852 |
US:MOT / | Director | 2 000 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Miles D White. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Miles D White som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-03-02 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −293 | 8 382 | −3,38 | 184,43 | −54 038 | 1 545 892 | |
2022-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 690 | 18 613 | 3,85 | 268,07 | 185 000 | 4 989 504 | |
2021-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −10 400 | 3 092 852 | −0,34 | ||||
2021-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −693 | 3 103 252 | −0,02 | ||||
2021-08-13 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 250 | 3 103 945 | −0,04 | ||||
2021-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −507 | 8 661 | −5,53 | ||||
2021-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 683 | 9 168 | 8,05 | ||||
2021-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −43 292 | 3 105 195 | −1,38 | 121,58 | −5 263 441 | 377 529 608 | |
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 227 272 | 227 272 | |||||
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 44 340 | 3 148 487 | 1,43 | ||||
2021-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −2 000 | 3 104 147 | −0,06 | ||||
2021-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 862 | 17 536 | 5,17 | 214,58 | 185 000 | 3 762 819 | |
2021-01-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 242 | 12 368 | 2,00 | 180,43 | 43 664 | 2 231 558 | |
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 844 | 3 106 147 | −0,06 | ||||
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −64 978 | 3 107 991 | −2,05 | ||||
2020-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −7 974 | 3 172 969 | −0,25 | ||||
2020-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 293 | 12 054 | 2,49 | 149,34 | 43 757 | 1 800 144 | |
2020-07-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 349 | 11 673 | 3,08 | 125,54 | 43 813 | 1 465 428 | |
2020-06-12 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 100 | 3 180 943 | −0,03 | ||||
2020-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 385 | 11 224 | 3,55 | 113,59 | 43 732 | 1 274 934 | |
2020-03-05 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −469 | 8 453 | −5,26 | 125,88 | −59 038 | 1 064 064 | |
2020-03-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −46 827 | 3 182 043 | −1,45 | 79,19 | −3 708 230 | 251 985 985 | |
2020-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 176 | 8 922 | 15,18 | ||||
2020-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 416 956 | 416 956 | |||||
2020-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 68 399 | 3 228 870 | 2,16 | ||||
2020-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 909 | 16 237 | 5,93 | 197,61 | 179 576 | 3 208 637 | |
2020-01-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 297 | 10 758 | 2,84 | 147,51 | 43 810 | 1 586 913 | |
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −298 | 3 160 471 | −0,01 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −12 382 | 3 160 769 | −0,39 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −507 | 0 | −100,00 | ||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 507 | 507 | |||||
2019-12-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 014 | 3 173 151 | −0,03 | ||||
2019-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 346 | 10 386 | 3,45 | 126,49 | 43 766 | 1 313 725 | |
2019-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 320 | 9 952 | 3,32 | 136,64 | 43 725 | 1 359 841 | |
2019-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 315 | 9 565 | 3,41 | 134,95 | 42 509 | 1 290 797 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −512 | 3 174 165 | −0,02 | 78,08 | −39 980 | 247 854 674 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 174 677 | 0,00 | 78,82 | −7 882 | 250 220 104 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 232 | 3 174 777 | −0,13 | 78,82 | −333 566 | 250 235 923 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 007 | 3 179 009 | −0,35 | 78,17 | −860 417 | 248 503 134 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 544 | 3 190 016 | −0,45 | 78,05 | −1 135 159 | 248 980 749 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 202 | 3 204 560 | −0,44 | 78,88 | −1 120 254 | 252 775 693 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −131 | 3 218 762 | 0,00 | 79,88 | −10 464 | 257 114 709 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 218 893 | −0,03 | 78,51 | −70 659 | 252 715 289 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 219 793 | −0,01 | 78,90 | −15 781 | 254 057 767 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 3 219 993 | −0,06 | 79,45 | −150 955 | 255 828 444 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 862 | 3 221 893 | −0,21 | 78,89 | −541 343 | 254 175 139 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −738 | 3 228 755 | −0,02 | 78,14 | −57 671 | 252 311 059 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −385 | 3 229 493 | −0,01 | 79,54 | −30 623 | 256 873 873 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 229 878 | −0,01 | 79,76 | −23 928 | 257 615 069 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 079 | 3 230 178 | −0,06 | 78,82 | −163 856 | 254 586 479 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 3 232 257 | −0,07 | 79,39 | −190 536 | 256 608 883 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −909 | 3 234 657 | −0,03 | 79,15 | −71 947 | 256 023 102 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 235 566 | 0,00 | 78,17 | −7 817 | 252 916 105 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 | 3 235 666 | 0,00 | 78,04 | −78 | 252 508 139 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 235 667 | 0,00 | 79,91 | −7 991 | 258 554 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 180 | 3 235 767 | −0,04 | 78,74 | −92 913 | 254 784 294 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 110 | 3 236 947 | −0,03 | 78,23 | −86 835 | 253 226 364 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 238 057 | −0,02 | 78,63 | −55 041 | 254 608 422 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 238 757 | −0,01 | 79,55 | −15 910 | 257 643 119 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 668 | 3 238 957 | −0,11 | 78,02 | −286 159 | 252 687 230 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 423 | 3 242 625 | −0,04 | 78,68 | −111 962 | 255 129 735 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 149 | 3 244 048 | −0,10 | 78,08 | −245 858 | 253 279 048 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 247 197 | 0,00 | 78,06 | −7 806 | 253 468 080 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 937 | 3 247 297 | −0,09 | 78,86 | −231 597 | 256 065 605 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −253 | 3 250 234 | −0,01 | 78,64 | −19 897 | 255 614 653 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 250 487 | −0,10 | 78,04 | −241 940 | 253 684 258 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 208 | 3 253 587 | −0,04 | 79,18 | −95 655 | 257 635 287 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −93 | 3 254 795 | 0,00 | 78,26 | −7 279 | 254 736 531 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 254 888 | −0,01 | 78,08 | −31 231 | 254 133 518 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 255 288 | −0,01 | 78,06 | −31 225 | 254 115 920 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 815 | 3 255 688 | −0,06 | 78,84 | −143 086 | 256 662 163 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 257 503 | −0,06 | 78,02 | −140 445 | 254 166 672 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 803 | 3 259 303 | −0,12 | 78,38 | −298 079 | 255 464 169 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 206 | 3 263 106 | −0,04 | 79,37 | −95 720 | 258 992 723 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 264 312 | −0,05 | 78,40 | −117 600 | 255 922 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 577 | 3 265 812 | −0,11 | 78,84 | −282 011 | 257 476 618 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 665 | 3 269 389 | −0,05 | 78,77 | −131 152 | 257 529 772 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 271 054 | −0,01 | 79,81 | −15 962 | 261 062 820 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 271 254 | −0,04 | 79,75 | −103 675 | 260 882 506 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 272 554 | −0,02 | 78,25 | −54 775 | 256 077 350 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 273 254 | −0,05 | 79,43 | −127 088 | 259 994 565 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 035 | 3 274 854 | −0,31 | 78,06 | −783 382 | 255 651 478 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 599 | 3 284 889 | −0,08 | 78,46 | −203 931 | 257 748 815 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 104 | 3 287 488 | −0,43 | 78,87 | −1 112 382 | 259 284 179 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 558 | 3 301 592 | −0,17 | 78,80 | −437 970 | 260 165 450 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 628 | 3 307 150 | −0,05 | 79,03 | −128 661 | 261 364 064 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −23 | 3 308 778 | 0,00 | 79,78 | −1 835 | 263 974 309 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −322 | 3 308 801 | −0,01 | 78,92 | −25 411 | 261 114 031 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 979 | 3 309 123 | −0,15 | 78,04 | −388 536 | 258 227 413 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 314 102 | −0,05 | 79,10 | −118 650 | 262 145 468 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 112 | 3 315 602 | −0,06 | 79,57 | −168 052 | 263 822 451 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 970 | 3 317 714 | −0,21 | 78,01 | −543 730 | 258 814 869 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 306 | 3 324 684 | −0,04 | 78,73 | −102 821 | 261 752 371 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 325 990 | −0,01 | 78,28 | −15 656 | 260 358 497 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 035 | 3 326 190 | −0,03 | 78,42 | −81 165 | 260 839 820 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 3 327 225 | −0,07 | 79,07 | −173 954 | 263 083 681 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 154 | 3 329 425 | −0,12 | 78,18 | −324 739 | 260 277 799 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 | 3 333 579 | 0,00 | 79,95 | −1 039 | 266 519 641 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 436 | 3 333 592 | −0,07 | 78,91 | −192 225 | 263 053 745 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 942 | 3 336 028 | −0,15 | 78,86 | −389 726 | 263 079 168 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 340 | 3 340 970 | −0,04 | 78,16 | −104 741 | 261 146 920 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 483 | 3 342 310 | −0,07 | 78,58 | −195 114 | 262 638 720 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −686 | 3 344 793 | −0,02 | 79,80 | −54 743 | 266 914 481 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 685 | 3 345 479 | −0,11 | 78,46 | −289 107 | 262 469 555 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 349 164 | −0,04 | 78,35 | −101 855 | 262 406 999 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 350 464 | −0,03 | 78,91 | −78 908 | 264 376 738 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −704 | 3 351 464 | −0,02 | 79,06 | −55 658 | 264 966 744 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 352 168 | −0,01 | 79,09 | −15 818 | 265 122 967 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | 1 100 | 3 352 368 | 0,03 | 79,56 | 87 516 | 266 714 398 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 353 468 | −0,05 | 78,49 | −125 584 | 263 213 703 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 330 | 3 355 068 | −0,19 | 78,08 | −494 246 | 261 963 709 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 361 398 | −0,01 | 78,56 | −39 280 | 264 071 427 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 925 | 3 361 898 | −0,06 | 78,02 | −150 188 | 262 295 282 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 037 | 3 363 823 | −0,18 | 79,49 | −479 881 | 267 390 290 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 369 860 | −0,01 | 79,50 | −39 750 | 267 903 870 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 499 | 3 370 360 | −0,10 | 78,88 | −275 984 | 265 837 145 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 373 859 | −0,03 | 79,27 | −71 343 | 267 445 803 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 374 759 | −0,09 | 79,46 | −246 326 | 268 158 350 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 900 | 3 377 859 | −0,35 | 78,00 | −928 260 | 263 489 891 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −504 | 3 389 759 | −0,01 | 78,74 | −39 682 | 266 892 675 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 3 390 263 | −0,07 | 79,40 | −190 560 | 269 186 882 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −877 | 3 392 663 | −0,03 | 79,47 | −69 695 | 269 614 929 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 807 | 3 393 540 | −0,05 | 78,26 | −141 416 | 265 578 440 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 523 | 3 395 347 | −0,40 | 78,00 | −1 054 794 | 264 837 066 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 | 3 408 870 | 0,00 | 78,70 | −157 | 268 295 113 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 | 3 408 872 | 0,00 | 79,06 | −79 | 269 522 465 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par valuef |
S - Sale | −1 800 | 3 408 873 | −0,05 | 79,18 | −142 524 | 269 914 564 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −36 669 | 3 410 673 | −1,06 | 78,06 | −2 862 382 | 266 237 134 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 447 342 | −0,01 | 78,64 | −23 590 | 271 081 738 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 447 642 | 0,00 | 79,71 | −7 971 | 274 811 544 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 800 | 3 447 742 | −0,17 | 78,66 | −456 228 | 271 199 386 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −75 | 3 453 542 | 0,00 | 78,20 | −5 865 | 270 049 717 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 816 | 3 453 617 | −0,05 | 78,84 | −143 183 | 272 300 432 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 455 433 | −0,05 | 78,93 | −142 074 | 272 737 327 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 457 233 | −0,04 | 79,08 | −102 804 | 273 397 986 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 458 533 | −0,01 | 79,68 | −23 904 | 275 575 909 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 891 | 3 458 833 | −0,17 | 78,47 | −462 267 | 271 414 626 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 701 | 3 464 724 | −0,19 | 78,76 | −527 771 | 272 881 662 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 471 425 | −0,01 | 78,36 | −39 180 | 272 020 863 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 094 | 3 471 925 | −0,18 | 78,80 | −480 177 | 273 570 330 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 044 | 3 478 019 | −0,09 | 79,02 | −240 537 | 274 833 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 481 063 | −0,01 | 79,41 | −15 882 | 276 431 213 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 481 263 | −0,03 | 79,59 | −87 549 | 277 073 722 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −570 | 3 482 363 | −0,02 | 79,65 | −45 400 | 277 370 213 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 482 933 | 0,00 | 79,40 | −7 940 | 276 562 295 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 275 | 3 483 033 | −0,09 | 78,72 | −257 808 | 274 184 358 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −20 | 3 486 308 | 0,00 | 79,52 | −1 590 | 277 248 644 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 100 | 3 486 328 | −0,06 | 78,50 | −164 850 | 273 676 748 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 181 | 3 488 428 | −0,09 | 78,10 | −248 420 | 272 428 785 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 700 | 3 491 609 | −0,48 | 78,86 | −1 317 046 | 275 365 744 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −265 | 3 508 309 | −0,01 | 78,58 | −20 822 | 275 665 380 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 508 574 | −0,05 | 78,44 | −141 201 | 275 230 087 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 611 | 3 510 374 | −0,30 | 78,09 | −828 613 | 274 125 106 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 200 | 3 520 985 | −0,46 | 79,91 | −1 294 542 | 281 361 911 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 3 537 185 | −0,06 | 78,30 | −172 260 | 276 961 586 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 802 | 3 539 385 | −0,05 | 78,46 | −141 385 | 277 700 147 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 357 | 3 541 187 | −0,07 | 78,88 | −185 932 | 279 346 536 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 110 | 3 543 544 | −0,06 | 79,19 | −167 091 | 280 613 249 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 678 | 3 545 654 | −0,10 | 79,14 | −291 077 | 280 603 058 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −140 | 3 549 332 | 0,00 | 78,16 | −10 942 | 277 398 042 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −509 | 3 549 472 | −0,01 | 78,78 | −40 102 | 279 645 152 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −420 | 3 549 981 | −0,01 | 79,25 | −33 285 | 281 335 994 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −531 | 3 550 401 | −0,01 | 78,72 | −41 798 | 279 469 815 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 223 | 3 550 932 | −0,03 | 78,78 | −96 348 | 279 742 423 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 3 552 155 | −0,05 | 79,16 | −150 404 | 281 188 590 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −687 | 3 554 055 | −0,02 | 78,48 | −53 912 | 278 904 466 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 282 | 3 554 742 | −0,20 | 78,14 | −569 015 | 277 767 540 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 562 024 | −0,01 | 79,38 | −23 814 | 282 753 465 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −18 702 | 3 562 324 | −0,52 | 78,07 | −1 460 065 | 278 110 635 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 581 026 | −0,01 | 79,60 | −23 880 | 285 049 670 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 660 | 3 581 326 | −0,05 | 78,76 | −130 750 | 282 083 142 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 336 | 3 582 986 | −0,04 | 79,13 | −105 718 | 283 521 682 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 011 | 3 584 322 | −0,06 | 78,82 | −158 517 | 282 534 182 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −494 | 3 586 333 | −0,01 | 78,21 | −38 636 | 280 487 104 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 233 | 3 586 827 | −0,20 | 78,79 | −569 888 | 282 606 099 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 594 060 | −0,01 | 78,99 | −23 697 | 283 894 799 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −69 | 3 594 360 | 0,00 | 79,90 | −5 513 | 287 189 364 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 594 429 | −0,01 | 79,87 | −39 935 | 287 087 044 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 956 | 3 594 929 | −0,22 | 78,04 | −620 886 | 280 548 259 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 277 | 3 602 885 | −0,06 | 78,67 | −179 132 | 283 438 963 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 605 162 | −0,02 | 78,72 | −55 108 | 283 816 378 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 900 | 3 605 862 | −0,11 | 79,17 | −308 763 | 285 476 095 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 337 | 3 609 762 | −0,09 | 78,48 | −261 888 | 283 294 122 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −805 | 3 613 099 | −0,02 | 78,78 | −63 414 | 284 621 874 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 613 904 | −0,03 | 79,63 | −95 556 | 287 775 176 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 615 104 | −0,02 | 79,42 | −63 536 | 287 111 560 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 465 | 3 615 904 | −0,04 | 78,41 | −114 871 | 283 523 033 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 617 369 | −0,02 | 79,22 | −71 298 | 286 567 972 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 974 | 3 618 269 | −0,30 | 78,16 | −857 728 | 282 803 905 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −212 | 3 629 243 | −0,01 | 79,52 | −16 858 | 288 597 403 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 629 455 | −0,01 | 79,00 | −31 600 | 286 726 945 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 629 855 | −0,04 | 79,74 | −111 636 | 289 444 638 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −450 | 3 631 255 | −0,01 | 78,37 | −35 266 | 284 581 454 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 915 | 3 631 705 | −0,08 | 79,48 | −231 684 | 288 647 913 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 998 | 3 634 620 | −0,08 | 79,04 | −236 962 | 287 280 365 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 185 | 3 637 618 | −0,11 | 78,83 | −329 904 | 286 753 427 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 641 803 | −0,01 | 79,24 | −15 848 | 288 576 470 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 642 003 | −0,04 | 78,54 | −117 810 | 286 042 916 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 262 | 3 643 503 | −0,06 | 78,57 | −177 725 | 286 270 031 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −123 | 3 645 765 | 0,00 | 79,48 | −9 775 | 289 747 173 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 645 888 | −0,03 | 78,45 | −86 295 | 286 019 914 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 691 | 3 646 988 | −0,05 | 78,75 | −133 166 | 287 200 305 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 237 | 3 648 679 | −0,06 | 78,81 | −176 298 | 287 552 392 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 095 | 3 650 916 | −0,38 | 78,85 | −1 111 391 | 287 874 727 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 739 | 3 665 011 | −0,07 | 78,70 | −215 559 | 288 436 366 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 667 750 | −0,02 | 78,22 | −46 932 | 286 891 405 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 261 | 3 668 350 | −0,06 | 78,27 | −176 968 | 287 121 754 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 670 611 | −0,01 | 79,20 | −15 840 | 290 703 215 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 171 | 3 670 811 | −0,03 | 78,80 | −92 281 | 289 278 261 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 206 | 3 671 982 | −0,06 | 78,20 | −172 509 | 287 148 992 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 674 188 | −0,02 | 79,79 | −63 832 | 293 163 461 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 709 | 3 674 988 | −0,10 | 78,03 | −289 413 | 286 759 314 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 675 | 3 678 697 | −0,15 | 78,18 | −443 672 | 287 600 531 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 754 | 3 684 372 | −0,10 | 78,10 | −293 187 | 287 749 453 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −294 700 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −295 000 | 0 | −100,00 | ||||
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 700 | 3 688 126 | −0,13 | 78,19 | −367 493 | 288 374 572 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 692 826 | 0,00 | 78,87 | −7 887 | 291 243 955 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 692 926 | 0,00 | 79,72 | −7 972 | 294 400 061 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 693 026 | 0,00 | 78,78 | −7 878 | 290 927 356 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 008 | 3 693 126 | −0,08 | 79,20 | −238 234 | 292 495 579 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 092 | 3 696 134 | −0,19 | 78,90 | −559 559 | 291 624 973 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 649 | 3 703 226 | −0,07 | 78,90 | −208 993 | 292 166 015 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −812 | 3 705 875 | −0,02 | 79,11 | −64 237 | 293 171 771 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 960 | 3 706 687 | −0,05 | 78,64 | −154 134 | 291 493 866 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 708 647 | −0,01 | 78,97 | −23 691 | 292 871 854 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −123 | 3 708 947 | 0,00 | 78,40 | −9 644 | 290 799 990 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 709 070 | 0,00 | 78,60 | −7 860 | 291 532 902 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 908 | 3 709 170 | −0,29 | 78,06 | −851 424 | 289 519 264 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 725 | 3 720 078 | −0,05 | 78,13 | −134 774 | 290 649 694 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 680 | 3 721 803 | −0,10 | 79,51 | −292 597 | 295 920 557 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 800 | 3 725 483 | −0,21 | 78,71 | −613 938 | 293 232 767 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 600 | 3 733 283 | −0,12 | 79,05 | −363 630 | 295 116 021 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 442 | 3 737 883 | −0,15 | 79,01 | −429 972 | 295 330 136 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −723 | 3 743 325 | −0,02 | 79,12 | −57 204 | 296 171 874 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 744 048 | −0,01 | 78,07 | −31 228 | 292 301 571 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 744 448 | 0,00 | 79,92 | −7 992 | 299 275 006 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 130 | 3 744 548 | −0,03 | 79,69 | −90 050 | 298 403 030 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 745 678 | −0,01 | 79,20 | −23 758 | 296 638 969 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −250 | 3 745 978 | −0,01 | 79,53 | −19 882 | 297 917 630 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 683 | 3 746 228 | −0,04 | 78,96 | −132 890 | 295 802 163 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 747 911 | 0,00 | 79,21 | −7 921 | 296 872 030 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 383 | 3 748 011 | −0,33 | 78,15 | −967 731 | 292 907 060 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 471 | 3 760 394 | −0,09 | 78,18 | −271 380 | 294 006 405 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 294 700 | 3 763 865 | 8,49 | 22,39 | 6 598 893 | 84 280 089 | |
2019-03-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 295 000 | 3 469 165 | 9,29 | 26,19 | 7 725 430 | 90 850 146 | |
2019-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −427 | 8 462 | −4,80 | 137,73 | −58 811 | 1 165 471 | |
2019-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 084 | 8 865 | 13,93 | ||||
2019-03-04 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −52 302 | 3 174 165 | −1,62 | 77,23 | −4 039 283 | 245 140 763 | |
2019-02-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 522 272 | 522 272 | |||||
2019-02-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 99 637 | 3 226 467 | 3,19 | ||||
2019-01-31 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −725 | 7 032 | −9,35 | 95,50 | −69 238 | 671 556 | |
2019-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 336 | 9 193 | 3,79 | 126,31 | 42 440 | 1 161 168 | |
2019-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 986 | 14 969 | 7,05 | 177,57 | 175 001 | 2 658 063 | |
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −6 071 | 3 126 830 | −0,19 | ||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −642 | 0 | −100,00 | ||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 642 | 642 | |||||
2018-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 284 | 3 132 901 | −0,04 | ||||
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −119 | 3 134 185 | 0,00 | 72,60 | −8 639 | 227 526 160 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 134 304 | −0,02 | 72,59 | −36 295 | 227 519 127 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 900 | 3 134 804 | −0,09 | 72,58 | −210 496 | 227 539 748 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 137 704 | −0,01 | 72,58 | −29 032 | 227 734 556 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 138 104 | −0,05 | 72,58 | −116 120 | 227 747 898 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 139 704 | 0,00 | 72,57 | −7 257 | 227 848 319 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 139 804 | 0,00 | 72,56 | −7 256 | 227 839 877 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 3 139 904 | −0,04 | 72,54 | −79 800 | 227 784 336 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 141 004 | −0,02 | 72,54 | −43 524 | 227 848 430 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 620 | 3 141 604 | −0,05 | 72,54 | −117 507 | 227 876 246 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 300 | 3 143 224 | −0,26 | 72,53 | −601 999 | 227 978 037 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −130 | 3 151 524 | 0,00 | 72,53 | −9 429 | 228 572 157 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 945 | 3 151 654 | −0,38 | 72,52 | −866 311 | 228 573 706 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 400 | 3 163 599 | −0,17 | 72,52 | −391 608 | 229 424 199 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −64 374 | 3 168 999 | −1,99 | 72,52 | −4 668 081 | 229 799 962 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 961 | 3 233 373 | −0,06 | 72,51 | −142 192 | 234 451 876 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 859 | 3 235 334 | −0,12 | 72,50 | −279 797 | 234 577 892 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 700 | 3 239 193 | −0,14 | 72,50 | −340 750 | 234 841 492 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 683 | 3 243 893 | −0,39 | 72,50 | −919 454 | 235 166 023 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 256 576 | −0,04 | 72,49 | −101 486 | 236 069 194 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 463 | 3 257 976 | −0,23 | 72,48 | −540 956 | 236 154 390 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 265 439 | −0,03 | 72,48 | −65 232 | 236 679 019 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −61 | 3 266 339 | 0,00 | 72,48 | −4 421 | 236 727 919 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −518 | 3 266 400 | −0,02 | 72,46 | −37 537 | 236 699 676 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −210 | 3 266 918 | −0,01 | 72,46 | −15 217 | 236 720 878 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 147 | 3 267 128 | −0,16 | 72,46 | −372 926 | 236 719 759 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 000 | 3 272 275 | −0,09 | 72,45 | −217 350 | 237 076 324 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 800 | 3 275 275 | −0,05 | 72,44 | −130 401 | 237 277 297 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −856 | 3 277 075 | −0,03 | 72,44 | −62 009 | 237 391 313 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 401 | 3 277 931 | −0,10 | 72,44 | −246 351 | 237 436 932 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 3 281 332 | −0,20 | 72,43 | −478 038 | 237 666 877 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 716 | 3 287 932 | −0,17 | 72,42 | −413 981 | 238 128 475 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 674 | 3 293 648 | −0,17 | 72,42 | −410 911 | 238 525 988 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 177 | 3 299 322 | −0,31 | 72,42 | −736 967 | 238 920 403 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 345 | 3 309 499 | −0,22 | 72,41 | −531 851 | 239 640 823 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −325 000 | 0 | −100,00 | ||||
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 538 | 3 316 844 | −0,38 | 72,40 | −907 814 | 240 156 090 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 564 | 3 329 382 | −0,41 | 72,40 | −982 034 | 241 047 257 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 022 | 3 342 946 | −0,30 | 72,40 | −725 543 | 242 012 576 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 3 352 968 | −0,09 | 72,39 | −224 409 | 242 721 354 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 462 | 3 356 068 | −0,16 | 72,38 | −395 367 | 242 928 982 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 200 | 3 361 530 | −0,15 | 72,38 | −376 376 | 243 307 541 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 761 | 3 366 730 | −0,05 | 72,38 | −127 452 | 243 667 084 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 916 | 3 368 491 | −0,06 | 72,37 | −138 661 | 243 777 694 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 008 | 3 370 407 | −0,09 | 72,36 | −217 674 | 243 899 503 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 800 | 3 373 415 | −0,11 | 72,36 | −274 968 | 244 100 309 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 181 | 3 377 215 | −0,21 | 72,36 | −519 581 | 244 358 391 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 250 | 3 384 396 | −0,13 | 72,35 | −307 488 | 244 861 051 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 290 | 3 388 646 | −0,42 | 72,34 | −1 033 810 | 245 151 595 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 825 | 3 402 936 | −0,20 | 72,34 | −493 720 | 246 168 390 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 460 | 3 409 761 | −0,10 | 72,34 | −250 279 | 246 645 062 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 595 | 3 413 221 | −0,05 | 72,33 | −115 366 | 246 878 275 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 945 | 3 414 816 | −0,20 | 72,32 | −502 297 | 246 976 567 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 100 | 3 421 761 | −0,15 | 72,32 | −368 832 | 247 461 756 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 3 426 861 | −0,07 | 72,32 | −166 324 | 247 813 453 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 385 | 3 429 161 | −0,13 | 72,31 | −317 079 | 247 962 632 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 757 | 3 433 546 | −0,31 | 72,30 | −777 785 | 248 262 544 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 381 | 3 444 303 | −0,04 | 72,30 | −99 846 | 249 023 107 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 327 | 3 445 684 | −0,04 | 72,30 | −95 935 | 249 105 725 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 102 | 3 447 011 | −0,06 | 72,29 | −151 954 | 249 184 425 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −231 | 3 449 113 | −0,01 | 72,29 | −16 698 | 249 327 756 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 870 | 3 449 344 | −0,14 | 72,28 | −352 028 | 249 335 831 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 771 | 3 454 214 | −0,08 | 72,28 | −200 288 | 249 670 588 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 456 985 | −0,04 | 72,28 | −101 185 | 249 853 591 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 458 385 | −0,02 | 72,27 | −57 816 | 249 937 484 | |
2018-11-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 325 000 | 3 459 185 | 10,37 | 26,02 | 8 454 875 | 89 990 698 | |
2018-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 280 | 8 795 | 3,29 | 151,74 | 42 487 | 1 334 553 | |
2018-07-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 311 | 8 461 | 3,82 | 136,72 | 42 520 | 1 156 788 | |
2018-06-07 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −23 923 | 3 134 185 | −0,76 | ||||
2018-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 289 | 8 112 | 3,69 | 147,17 | 42 532 | 1 193 843 | |
2018-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −549 | 7 757 | −6,61 | 153,33 | −84 178 | 1 189 381 | |
2018-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 993 | 8 306 | 13,58 | ||||
2018-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −53 462 | 3 158 108 | −1,66 | 60,55 | −3 237 124 | 191 223 439 | |
2018-02-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 688 073 | 688 073 | |||||
2018-02-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 125 125 | 3 211 570 | 4,05 | ||||
2018-01-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −440 | 3 086 445 | −0,01 | ||||
2018-01-05 |
|
4/A | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −22 890 | 3 123 692 | −0,73 | ||||
2018-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 988 | 13 637 | 7,81 | 172,12 | 169 999 | 2 347 278 | |
2018-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 269 | 7 784 | 3,58 | 158,00 | 42 502 | 1 229 872 | |
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −455 | 3 086 430 | −0,01 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −36 352 | 3 086 885 | −1,16 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −23 345 | 3 123 237 | −0,74 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 9 992 | 2,46 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 136 692 | 0,18 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 9 992 | 2,46 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 240 | 136 692 | 0,18 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −720 | 0 | −100,00 | ||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 720 | 720 | |||||
2017-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 440 | 3 146 582 | −0,05 | ||||
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 279 290 | −0,09 | 54,59 | −152 852 | 179 016 441 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −505 | 3 282 090 | −0,02 | 54,58 | −27 565 | 179 152 883 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 101 | 3 282 595 | −0,06 | 54,58 | −114 673 | 179 164 035 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −692 | 3 284 696 | −0,02 | 54,58 | −37 766 | 179 262 284 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 001 | 3 285 388 | −0,18 | 54,57 | −327 475 | 179 283 623 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 291 389 | −0,01 | 54,57 | −10 914 | 179 602 869 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 902 | 3 291 589 | −0,06 | 54,56 | −103 783 | 179 605 554 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 345 | 3 293 491 | −0,16 | 54,56 | −291 623 | 179 692 869 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 660 | 3 298 836 | −0,05 | 54,56 | −90 561 | 179 967 998 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 512 | 3 300 496 | −0,05 | 54,55 | −82 480 | 180 042 057 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 302 008 | −0,01 | 54,54 | −21 818 | 180 108 026 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 302 408 | −0,04 | 54,54 | −65 448 | 180 113 332 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 303 608 | −0,02 | 54,54 | −43 628 | 180 162 262 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 300 | 3 304 408 | −0,22 | 54,53 | −398 069 | 180 189 368 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 799 | 3 311 708 | −0,05 | 54,52 | −98 090 | 180 570 879 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 200 | 3 313 507 | −0,10 | 54,52 | −174 464 | 180 652 402 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 316 707 | 0,00 | 54,52 | −5 452 | 180 818 574 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −607 | 3 316 807 | −0,02 | 54,52 | −33 091 | 180 815 734 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 3 317 414 | −0,20 | 54,51 | −359 766 | 180 832 237 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 882 | 3 324 014 | −0,06 | 54,50 | −102 578 | 181 175 383 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 892 | 3 325 896 | −0,33 | 54,50 | −593 614 | 181 261 332 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 336 788 | 0,00 | 54,50 | −5 450 | 181 846 604 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 289 | 3 336 888 | −0,19 | 54,50 | −342 719 | 181 843 712 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 800 | 3 343 177 | −0,32 | 54,49 | −588 492 | 182 169 715 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 184 | 3 353 977 | −0,15 | 54,48 | −282 450 | 182 741 437 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 711 | 3 359 161 | −0,38 | 54,48 | −692 495 | 183 007 091 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 3 371 872 | −0,07 | 54,48 | −136 188 | 183 682 727 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 436 | 3 374 372 | −0,22 | 54,47 | −405 039 | 183 802 043 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 359 | 3 381 808 | −0,04 | 54,46 | −74 018 | 184 190 173 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −17 860 | 3 383 167 | −0,53 | 54,46 | −972 656 | 184 247 275 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −530 000 | 0 | −100,00 | ||||
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 377 | 3 401 027 | −0,07 | 54,46 | −129 440 | 185 202 925 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 800 | 3 403 404 | −0,40 | 54,45 | −751 410 | 185 315 348 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 501 | 3 417 204 | −0,10 | 54,44 | −190 612 | 186 049 672 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 150 | 3 420 705 | −0,27 | 54,44 | −498 126 | 186 223 180 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 833 | 3 429 855 | −0,31 | 54,44 | −589 694 | 186 704 157 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −19 665 | 3 440 688 | −0,57 | 54,43 | −1 070 366 | 187 276 648 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −21 402 | 3 460 353 | −0,61 | 54,42 | −1 164 804 | 188 329 712 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −39 699 | 3 481 755 | −1,13 | 54,42 | −2 160 420 | 189 477 107 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 521 454 | 0,00 | 54,42 | −5 442 | 191 628 723 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 167 | 3 521 554 | −0,23 | 54,42 | −444 407 | 191 625 361 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −24 651 | 3 529 721 | −0,69 | 54,41 | −1 341 261 | 192 052 120 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 554 372 | 0,00 | 54,41 | −5 441 | 193 384 495 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 181 | 3 554 472 | −0,40 | 54,40 | −771 517 | 193 381 049 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −19 900 | 3 568 653 | −0,55 | 54,40 | −1 082 560 | 194 134 723 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 588 553 | 0,00 | 54,40 | −5 440 | 195 208 312 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 435 | 3 588 653 | −0,15 | 54,40 | −295 637 | 195 204 780 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −27 636 | 3 594 088 | −0,76 | 54,39 | −1 503 122 | 195 482 446 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 502 | 3 621 724 | −0,23 | 54,38 | −462 381 | 196 967 460 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −16 446 | 3 630 226 | −0,45 | 54,38 | −894 333 | 197 411 690 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 199 | 3 646 672 | −0,14 | 54,38 | −282 696 | 198 287 790 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 035 | 3 651 871 | −0,22 | 54,37 | −436 863 | 198 552 226 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 407 | 3 659 906 | −0,07 | 54,36 | −130 857 | 198 970 790 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 450 | 3 662 313 | −0,20 | 54,36 | −404 982 | 199 083 335 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 650 | 3 669 763 | −0,07 | 54,36 | −144 041 | 199 469 968 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −800 | 3 672 413 | −0,02 | 54,35 | −43 480 | 199 595 647 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 3 673 213 | −0,01 | 54,34 | −16 304 | 199 620 760 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 673 513 | −0,03 | 54,34 | −54 340 | 199 618 696 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 674 513 | −0,08 | 54,33 | −152 124 | 199 636 291 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 677 313 | −0,02 | 54,32 | −32 595 | 199 770 029 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 530 000 | 3 677 913 | 16,84 | 26,70 | 14 149 569 | 98 190 347 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −204 | 3 148 022 | −0,01 | 55,02 | −11 224 | 173 204 170 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 148 117 | 0,00 | 55,00 | −5 500 | 173 146 435 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 148 217 | −0,02 | 54,99 | −32 994 | 173 120 453 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −615 | 3 148 817 | −0,02 | 54,98 | −33 813 | 173 121 959 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 149 432 | −0,01 | 54,98 | −10 995 | 173 140 024 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 199 | 3 149 632 | −0,04 | 54,97 | −65 909 | 173 135 271 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 150 831 | 0,00 | 54,96 | −5 496 | 173 185 426 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 150 931 | −0,01 | 54,96 | −21 984 | 173 175 168 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 | 3 151 331 | 0,00 | 54,96 | −165 | 173 181 395 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −428 | 3 151 334 | −0,01 | 54,95 | −23 519 | 173 165 803 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 151 762 | −0,01 | 54,94 | −10 989 | 173 173 563 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 151 962 | −0,04 | 54,94 | −65 928 | 173 168 792 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 600 | 3 153 162 | −0,05 | 54,93 | −87 888 | 173 203 189 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −392 | 3 154 762 | −0,01 | 54,92 | −21 531 | 173 275 303 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 300 | 3 155 154 | −0,10 | 54,92 | −181 236 | 173 281 058 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −103 | 3 158 454 | 0,00 | 54,92 | −5 656 | 173 446 501 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 207 | 3 158 557 | −0,07 | 54,91 | −121 186 | 173 436 365 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −797 | 3 160 764 | −0,03 | 54,90 | −43 759 | 173 541 747 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 618 | 3 161 561 | −0,05 | 54,90 | −88 828 | 173 569 699 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −499 | 3 163 179 | −0,02 | 54,90 | −27 393 | 173 642 711 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 3 163 678 | −0,05 | 54,89 | −82 335 | 173 654 285 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 103 | 3 165 178 | −0,10 | 54,88 | −170 293 | 173 704 969 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 168 281 | 0,00 | 54,88 | −5 488 | 173 859 420 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 897 | 3 168 381 | −0,12 | 54,87 | −213 828 | 173 849 065 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −197 | 3 172 278 | −0,01 | 54,86 | −10 808 | 174 047 032 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 3 172 475 | −0,08 | 54,86 | −137 150 | 174 041 978 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −144 | 3 174 975 | 0,00 | 54,86 | −7 899 | 174 163 254 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 975 | 3 175 119 | −0,22 | 54,85 | −382 579 | 174 155 277 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 359 | 3 182 094 | −0,07 | 54,84 | −129 379 | 174 521 945 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 297 | 3 184 453 | −0,13 | 54,84 | −235 647 | 174 635 403 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 188 750 | −0,03 | 54,84 | −54 835 | 174 855 106 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 403 | 3 189 750 | −0,08 | 54,83 | −131 756 | 174 893 992 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 192 153 | −0,01 | 54,82 | −10 965 | 175 009 788 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 500 | 3 192 353 | −0,14 | 54,82 | −246 690 | 175 004 791 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 602 | 3 196 853 | −0,05 | 54,82 | −87 814 | 175 235 497 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 3 198 455 | −0,19 | 54,81 | −339 822 | 175 307 319 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −398 | 3 204 655 | −0,01 | 54,80 | −21 812 | 175 631 117 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 600 | 3 205 053 | −0,17 | 54,80 | −306 880 | 175 636 904 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 200 | 3 210 653 | −0,04 | 54,80 | −65 754 | 175 927 731 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 3 211 853 | −0,07 | 54,79 | −126 017 | 175 977 426 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 3 214 153 | −0,04 | 54,78 | −76 699 | 176 087 372 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 898 | 3 215 553 | −0,12 | 54,78 | −213 532 | 176 147 993 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 097 | 3 219 451 | −0,03 | 54,78 | −60 088 | 176 345 429 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 439 | 3 220 548 | −0,14 | 54,77 | −243 124 | 176 389 414 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −398 | 3 224 987 | −0,01 | 54,76 | −21 796 | 176 616 413 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 702 | 3 225 385 | −0,15 | 54,76 | −257 482 | 176 622 083 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 156 | 3 230 087 | −0,04 | 54,76 | −63 297 | 176 863 414 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 600 | 3 231 243 | −0,08 | 54,75 | −142 350 | 176 910 554 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −606 | 3 233 843 | −0,02 | 54,74 | −33 175 | 177 036 735 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 500 | 3 234 449 | −0,14 | 54,74 | −246 330 | 177 053 738 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 534 | 3 238 949 | −0,05 | 54,74 | −83 963 | 177 283 874 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 760 | 3 240 483 | −0,05 | 54,73 | −96 325 | 177 351 635 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −866 | 3 242 243 | −0,03 | 54,72 | −47 392 | 177 431 748 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 500 | 3 243 109 | −0,17 | 54,72 | −300 960 | 177 462 924 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 000 | 3 248 609 | −0,09 | 54,72 | −164 145 | 177 747 641 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 900 | 3 251 609 | −0,18 | 54,71 | −322 789 | 177 895 528 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 3 257 509 | −0,03 | 54,70 | −54 705 | 178 202 030 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 706 | 3 258 509 | −0,08 | 54,70 | −148 018 | 178 240 442 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −394 | 3 261 215 | −0,01 | 54,70 | −21 550 | 178 372 154 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 3 261 609 | −0,09 | 54,69 | −153 132 | 178 377 396 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 264 409 | −0,04 | 54,68 | −71 090 | 178 514 206 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 700 | 3 265 709 | −0,05 | 54,68 | −92 956 | 178 568 968 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 267 409 | −0,02 | 54,68 | −38 272 | 178 645 587 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 268 109 | −0,02 | 54,67 | −38 269 | 178 667 519 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 268 809 | −0,01 | 54,66 | −10 933 | 178 689 444 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 700 | 3 269 009 | −0,05 | 54,66 | −92 922 | 178 684 032 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 3 270 709 | −0,02 | 54,66 | −27 328 | 178 760 600 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 3 271 209 | −0,01 | 54,64 | −21 856 | 178 738 860 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 3 271 609 | −0,02 | 54,64 | −38 244 | 178 744 358 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 3 272 309 | −0,04 | 54,63 | −71 019 | 178 766 241 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −900 | 3 273 609 | −0,03 | 54,62 | −49 158 | 178 804 524 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 3 274 509 | 0,00 | 54,62 | −5 462 | 178 837 309 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 3 274 609 | −0,01 | 54,61 | −10 922 | 178 826 397 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −295 | 3 274 809 | −0,01 | 54,60 | −16 108 | 178 820 945 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 586 | 3 275 104 | −0,11 | 54,60 | −195 796 | 178 820 678 | |
2017-12-08 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 3 278 690 | −0,02 | 54,60 | −32 757 | 179 000 081 | |
2017-12-05 |
|
4/A | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 92 342 | 3 207 105 | 2,96 | ||||
2017-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 340 | 7 473 | 4,77 | 125,03 | 42 510 | 934 349 | |
2017-07-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 397 | 7 085 | 5,94 | 106,94 | 42 455 | 757 670 | |
2017-04-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 459 | 6 637 | 7,43 | 92,63 | 42 517 | 614 785 | |
2017-03-08 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 307 | 7 313 | 21,76 | ||||
2017-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −59 192 | 3 143 077 | −1,85 | 45,46 | −2 690 868 | 142 884 280 | |
2017-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 638 629 | 638 629 | |||||
2017-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 92 342 | 3 202 269 | 2,97 | ||||
2017-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 238 | 12 335 | 11,16 | 121,72 | 150 725 | 1 501 398 | |
2017-01-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 458 | 6 131 | 8,07 | 92,79 | 42 498 | 568 895 | |
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 3 178 381 | 0,01 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 129 888 | 0,26 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 9 512 | 3,71 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 340 | 9 512 | 3,71 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 020 | 0 | −100,00 | ||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 1 020 | 1 020 | |||||
2016-12-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −2 040 | 3 109 927 | −0,07 | ||||
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 3 111 967 | 0,07 | 40,70 | 89 529 | 126 641 497 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 3 109 767 | 0,03 | 40,58 | 36 526 | 126 209 894 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 911 | 3 108 867 | 0,19 | 40,72 | 240 725 | 126 608 609 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 102 956 | 0,03 | 40,62 | 40 615 | 126 026 558 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 3 101 956 | 0,08 | 40,45 | 97 080 | 125 474 120 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 550 | 3 099 556 | 0,11 | 40,74 | 144 645 | 126 291 409 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 424 | 3 096 006 | 0,05 | 40,59 | 57 800 | 125 666 884 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 000 | 3 094 582 | 0,29 | 40,73 | 366 570 | 126 042 325 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 900 | 3 085 582 | 0,13 | 40,57 | 158 223 | 125 182 062 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 081 682 | 0,02 | 40,72 | 20 361 | 125 493 795 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 081 182 | 0,01 | 40,64 | 8 129 | 125 234 642 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 3 080 982 | 0,06 | 40,60 | 73 080 | 125 087 869 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 500 | 3 079 182 | 0,15 | 40,66 | 182 948 | 125 184 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 300 | 3 074 682 | 0,11 | 40,68 | 134 260 | 125 093 437 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 900 | 3 071 382 | 0,09 | 40,58 | 117 682 | 124 636 682 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 700 | 3 068 482 | 0,09 | 40,63 | 109 701 | 124 672 424 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 3 065 782 | 0,06 | 40,74 | 69 250 | 124 884 630 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 978 | 3 064 082 | 0,20 | 40,76 | 243 633 | 124 876 662 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 058 104 | 0,03 | 40,54 | 40 540 | 123 975 536 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 057 104 | 0,03 | 40,70 | 40 705 | 124 439 418 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 700 | 3 056 104 | 0,02 | 40,54 | 28 382 | 123 909 737 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 055 404 | 0,00 | 40,71 | 4 071 | 124 393 135 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 3 055 304 | 0,05 | 40,62 | 64 992 | 124 106 448 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 700 | 3 053 704 | 0,02 | 40,49 | 28 343 | 123 644 475 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 100 | 3 053 004 | 0,04 | 40,67 | 44 737 | 124 165 673 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 402 | 3 051 904 | 0,08 | 40,44 | 97 137 | 123 418 998 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 3 049 502 | 0,07 | 40,48 | 85 008 | 123 443 841 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 100 | 3 047 402 | 0,20 | 40,65 | 247 965 | 123 876 891 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 041 302 | 0,01 | 40,73 | 8 146 | 123 879 834 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 3 041 102 | 0,06 | 40,60 | 77 150 | 123 483 947 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 039 202 | 0,03 | 40,47 | 40 470 | 122 996 505 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 3 038 202 | 0,05 | 40,77 | 57 078 | 123 867 496 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 036 802 | 0,02 | 40,51 | 20 255 | 123 020 849 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 036 302 | 0,00 | 40,74 | 4 074 | 123 706 534 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 389 | 3 036 202 | 0,21 | 40,72 | 260 160 | 123 634 145 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 3 029 813 | 0,01 | 40,64 | 8 128 | 123 139 175 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 3 029 613 | 0,02 | 40,44 | 24 267 | 122 532 698 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 225 | 3 029 013 | 0,11 | 40,74 | 131 386 | 123 401 990 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 3 025 788 | 0,02 | 40,44 | 24 261 | 122 347 738 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 3 025 188 | 0,03 | 40,66 | 32 528 | 123 004 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 600 | 3 024 388 | 0,09 | 40,72 | 105 859 | 123 137 957 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 3 021 788 | 0,00 | 40,80 | 4 080 | 123 273 841 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 3 021 688 | 0,04 | 40,75 | 48 903 | 123 141 340 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 3 020 488 | 0,01 | 40,76 | 16 305 | 123 122 642 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 3 020 088 | 0,03 | 40,76 | 32 612 | 123 113 887 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 3 019 288 | 0,04 | 40,56 | 52 722 | 122 447 225 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 440 | 3 017 988 | 0,05 | 40,55 | 58 392 | 122 379 413 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 3 016 548 | 0,03 | 40,46 | 40 455 | 122 034 449 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 3 015 548 | 0,01 | 40,50 | 12 148 | 122 114 616 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 900 | 3 015 248 | 0,13 | 40,76 | 158 964 | 122 901 508 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 605 | 3 011 348 | 0,05 | 40,64 | 65 227 | 122 381 183 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 3 009 743 | 0,02 | 40,53 | 20 265 | 121 984 884 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 300 | 3 009 243 | 0,14 | 40,71 | 175 053 | 122 506 283 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 3 004 943 | 0,08 | 40,61 | 97 464 | 122 030 735 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 300 | 3 002 543 | 0,11 | 40,56 | 133 848 | 121 783 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 999 243 | 0,02 | 40,79 | 20 395 | 122 339 122 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 998 743 | 0,07 | 40,60 | 85 250 | 121 733 972 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 996 643 | 0,01 | 40,68 | 8 135 | 121 888 454 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 996 443 | 0,09 | 40,68 | 113 904 | 121 895 301 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 776 | 2 993 643 | 0,16 | 40,75 | 194 622 | 121 990 952 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 988 867 | 0,06 | 40,78 | 69 326 | 121 885 996 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 13 700 | 2 987 167 | 0,46 | 40,46 | 554 302 | 120 860 777 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 000 | 2 973 467 | 0,10 | 40,46 | 121 395 | 120 321 342 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 2 970 467 | 0,03 | 40,58 | 32 460 | 120 526 699 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 969 667 | 0,03 | 40,52 | 40 520 | 120 330 907 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 968 667 | 0,07 | 40,70 | 89 540 | 120 824 747 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 400 | 2 966 467 | 0,08 | 40,69 | 97 656 | 120 705 542 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 964 067 | 0,07 | 40,80 | 85 680 | 120 933 934 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 000 | 2 961 967 | 0,07 | 40,42 | 80 840 | 119 722 706 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 959 967 | 0,03 | 40,40 | 40 395 | 119 567 867 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 16 690 | 2 958 967 | 0,57 | 40,45 | 675 110 | 119 690 215 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 942 277 | 0,05 | 40,59 | 64 944 | 119 427 023 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 622 | 2 940 677 | 0,06 | 40,38 | 65 488 | 118 729 834 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 025 | 2 939 055 | 0,14 | 40,39 | 162 570 | 118 708 431 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 935 030 | 0,02 | 40,42 | 24 249 | 118 619 237 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 800 | 2 934 430 | 0,13 | 40,57 | 154 166 | 119 049 825 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 500 | 2 930 630 | 0,05 | 40,40 | 60 608 | 118 412 105 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 929 130 | 0,06 | 40,60 | 77 140 | 118 922 678 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 700 | 2 927 230 | 0,13 | 40,58 | 150 146 | 118 786 993 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 923 530 | 0,02 | 40,63 | 20 315 | 118 783 024 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 923 030 | 0,01 | 40,46 | 8 092 | 118 273 101 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 922 830 | 0,08 | 40,52 | 89 133 | 118 418 457 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 265 | 2 920 630 | 0,18 | 40,38 | 212 601 | 117 935 039 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 915 365 | 0,05 | 40,54 | 56 756 | 118 188 897 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 678 | 2 913 965 | 0,06 | 40,36 | 67 732 | 117 622 197 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 912 287 | 0,02 | 40,50 | 20 252 | 117 962 185 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 17 900 | 2 911 787 | 0,62 | 40,40 | 723 160 | 117 636 195 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 893 887 | 0,01 | 40,35 | 8 070 | 116 768 340 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 893 687 | 0,00 | 40,44 | 4 044 | 117 027 936 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 293 | 2 893 587 | 0,04 | 40,49 | 52 354 | 117 161 338 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 892 294 | 0,00 | 40,67 | 4 067 | 117 629 597 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 37 120 | 2 892 194 | 1,30 | 40,44 | 1 501 133 | 116 960 325 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 479 | 2 855 074 | 0,19 | 40,48 | 221 790 | 115 573 396 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 849 595 | 0,02 | 40,44 | 20 220 | 115 240 471 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 849 095 | 0,01 | 40,65 | 12 195 | 115 815 712 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 848 795 | 0,02 | 40,42 | 20 212 | 115 162 538 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 848 295 | 0,10 | 40,47 | 113 316 | 115 270 499 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 100 | 2 845 495 | 0,25 | 40,51 | 287 621 | 115 271 002 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 838 395 | 0,20 | 40,37 | 230 109 | 114 586 006 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 320 | 2 832 695 | 0,19 | 40,44 | 215 167 | 114 568 349 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 500 | 2 827 375 | 0,09 | 40,44 | 101 088 | 114 324 908 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 211 | 2 824 875 | 0,04 | 40,48 | 49 027 | 114 365 064 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 823 664 | 0,01 | 40,52 | 16 210 | 114 428 984 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 823 264 | 0,08 | 40,55 | 89 210 | 114 483 355 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 600 | 2 821 064 | 0,13 | 40,46 | 145 638 | 114 126 144 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 200 | 2 817 464 | 0,18 | 40,50 | 210 600 | 114 107 292 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 996 | 2 812 264 | 0,04 | 40,50 | 40 333 | 113 882 631 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 811 268 | 0,00 | 40,64 | 4 064 | 114 249 932 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 811 168 | 0,06 | 40,53 | 68 901 | 113 936 639 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 100 | 2 809 468 | 0,04 | 40,61 | 44 671 | 114 092 495 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 210 | 2 808 368 | 0,19 | 40,56 | 211 318 | 113 907 406 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 803 158 | 0,02 | 40,68 | 24 408 | 114 032 467 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 8 649 | 2 802 558 | 0,31 | 40,36 | 349 074 | 113 111 241 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 793 909 | 0,01 | 40,41 | 8 082 | 112 908 847 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 121 | 2 793 709 | 0,18 | 40,43 | 207 042 | 112 949 655 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 900 | 2 788 588 | 0,36 | 40,46 | 400 554 | 112 826 270 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 021 | 2 778 688 | 0,07 | 40,48 | 81 800 | 112 467 397 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 776 667 | 0,05 | 40,46 | 56 651 | 112 357 830 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 775 267 | 0,04 | 40,52 | 48 624 | 112 453 819 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 774 067 | 0,00 | 40,52 | 4 052 | 112 412 130 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 773 967 | 0,02 | 40,38 | 24 231 | 112 026 657 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 11 100 | 2 773 367 | 0,40 | 40,41 | 448 551 | 112 071 760 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 762 267 | 0,01 | 40,47 | 12 142 | 111 795 851 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 761 967 | 0,02 | 40,75 | 24 450 | 112 550 155 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 761 367 | 0,00 | 40,74 | 4 074 | 112 511 898 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 761 267 | 0,01 | 40,74 | 16 296 | 112 494 018 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 760 867 | 0,01 | 40,73 | 12 219 | 112 450 113 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 760 567 | 0,00 | 40,72 | 4 072 | 112 424 091 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 000 | 2 760 467 | 0,04 | 40,72 | 40 720 | 112 406 216 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 759 467 | 0,05 | 40,72 | 52 930 | 112 351 699 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 758 167 | 0,05 | 40,71 | 52 923 | 112 284 979 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 756 867 | 0,01 | 40,70 | 12 212 | 112 218 271 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 756 567 | 0,04 | 40,70 | 48 840 | 112 192 277 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 200 | 2 755 367 | 0,04 | 40,70 | 48 834 | 112 129 660 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 754 167 | 0,06 | 40,69 | 65 104 | 112 067 055 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 150 | 2 752 567 | 0,04 | 40,68 | 46 788 | 111 988 188 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 751 417 | 0,06 | 40,68 | 69 156 | 111 927 644 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 800 | 2 749 717 | 0,03 | 40,68 | 32 540 | 111 844 739 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 700 | 2 748 917 | 0,10 | 40,67 | 109 809 | 111 798 454 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 746 217 | 0,02 | 40,66 | 24 399 | 111 674 914 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 745 617 | 0,06 | 40,66 | 69 122 | 111 636 787 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 743 917 | 0,02 | 40,66 | 24 393 | 111 553 946 | |
2016-11-14 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 743 317 | 0,05 | 40,65 | 52 845 | 111 515 836 | |
2016-10-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 481 | 5 623 | 9,35 | 88,40 | 42 520 | 497 073 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 742 017 | 0,01 | 43,37 | 8 674 | 118 921 277 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 300 | 2 741 817 | 0,19 | 43,30 | 229 490 | 118 720 676 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 600 | 2 736 517 | 0,02 | 43,38 | 26 031 | 118 723 790 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 735 917 | 0,00 | 43,33 | 4 333 | 118 554 123 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 000 | 2 735 817 | 0,11 | 43,34 | 130 035 | 118 583 988 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 000 | 2 732 817 | 0,07 | 43,35 | 86 700 | 118 467 617 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 800 | 2 730 817 | 0,18 | 43,36 | 208 152 | 118 421 879 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 726 017 | 0,02 | 43,38 | 21 690 | 118 254 617 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 2 725 517 | 0,03 | 43,32 | 38 984 | 118 055 769 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 724 617 | 0,01 | 43,28 | 12 984 | 117 921 424 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 233 | 2 724 317 | 0,01 | 43,30 | 10 089 | 117 969 737 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 067 | 2 724 084 | 0,22 | 43,31 | 262 762 | 117 980 078 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 700 | 2 718 017 | 0,17 | 43,34 | 203 698 | 117 798 857 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 100 | 2 713 317 | 0,26 | 43,33 | 307 643 | 117 568 026 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 706 217 | 0,06 | 43,28 | 69 256 | 117 138 603 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 500 | 2 704 617 | 0,13 | 43,30 | 151 532 | 117 096 393 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 400 | 2 701 117 | 0,13 | 43,36 | 147 407 | 117 106 928 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 900 | 2 697 717 | 0,11 | 43,36 | 125 744 | 116 973 009 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 141 | 2 694 817 | 0,04 | 43,38 | 49 491 | 116 887 687 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 693 676 | 0,00 | 43,34 | 4 334 | 116 750 652 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 200 | 2 693 576 | 0,27 | 43,32 | 311 940 | 116 699 180 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 780 | 2 686 376 | 0,10 | 43,34 | 120 471 | 116 414 104 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 879 | 2 683 596 | 0,48 | 43,30 | 557 725 | 116 213 125 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 800 | 2 670 717 | 0,29 | 43,32 | 337 896 | 115 695 460 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 662 917 | 0,02 | 43,39 | 21 695 | 115 543 969 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 662 417 | 0,07 | 43,29 | 82 251 | 115 256 032 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 500 | 2 660 517 | 0,02 | 43,26 | 21 630 | 115 096 626 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 600 | 2 660 017 | 0,36 | 43,12 | 413 952 | 114 699 933 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 641 | 2 650 417 | 0,48 | 43,13 | 545 206 | 114 312 485 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 637 776 | 0,01 | 43,26 | 8 652 | 114 116 784 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 637 776 | 0,01 | 43,26 | 8 652 | 114 116 784 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 700 | 2 637 576 | 0,06 | 43,30 | 73 610 | 114 207 041 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 635 876 | 0,11 | 43,26 | 121 114 | 114 014 816 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 633 076 | 0,00 | 43,12 | 4 312 | 113 544 820 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 979 | 2 632 976 | 0,23 | 43,18 | 258 143 | 113 678 739 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 101 | 2 626 997 | 0,16 | 43,10 | 176 733 | 113 210 436 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 899 | 2 622 896 | 0,42 | 43,11 | 469 856 | 113 073 047 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 42 445 | 2 611 997 | 1,65 | 43,27 | 1 836 595 | 113 021 110 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 772 | 2 569 552 | 0,07 | 43,16 | 76 488 | 110 914 712 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 300 | 2 567 780 | 0,09 | 43,20 | 99 372 | 110 940 935 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 18 000 | 2 565 280 | 0,71 | 43,37 | 780 660 | 111 256 194 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 400 | 2 547 280 | 0,17 | 43,30 | 190 520 | 110 297 224 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 909 | 2 542 880 | 0,04 | 43,38 | 39 437 | 110 322 849 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 622 | 2 541 971 | 0,06 | 43,26 | 70 160 | 109 952 956 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 900 | 2 540 349 | 0,27 | 43,34 | 299 080 | 110 111 427 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 200 | 2 533 449 | 0,29 | 43,35 | 312 120 | 109 825 014 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 200 | 2 526 249 | 0,09 | 43,27 | 95 194 | 109 310 794 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 656 | 2 524 049 | 0,38 | 43,36 | 418 732 | 109 455 385 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 514 393 | 0,23 | 43,38 | 247 266 | 109 074 368 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 508 693 | 0,01 | 43,25 | 12 976 | 108 507 244 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 400 | 2 508 393 | 0,22 | 43,23 | 233 442 | 108 437 829 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 700 | 2 502 993 | 0,23 | 43,28 | 246 696 | 108 329 537 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 100 | 2 497 293 | 0,16 | 43,40 | 177 920 | 108 370 030 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 914 | 2 493 193 | 0,16 | 43,31 | 169 515 | 107 980 189 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 100 | 2 489 279 | 0,25 | 43,34 | 264 374 | 107 885 352 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 100 | 2 483 179 | 0,12 | 43,40 | 134 556 | 107 782 384 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 910 | 2 480 079 | 0,12 | 43,33 | 126 090 | 107 461 823 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 452 | 2 477 169 | 0,14 | 43,28 | 149 420 | 107 224 260 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 400 | 2 473 717 | 0,02 | 43,30 | 17 318 | 107 099 578 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 108 | 2 473 317 | 0,00 | 43,38 | 4 685 | 107 298 675 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 473 209 | 0,00 | 43,23 | 4 323 | 106 923 008 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 473 109 | 0,01 | 43,32 | 8 664 | 107 141 265 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 300 | 2 472 909 | 0,21 | 43,36 | 229 782 | 107 212 970 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 148 | 2 467 609 | 0,01 | 43,28 | 6 405 | 106 785 779 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 2 467 461 | 0,07 | 43,26 | 77 868 | 106 742 363 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 465 661 | 0,00 | 43,39 | 4 339 | 106 991 195 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 465 561 | 0,00 | 43,31 | 4 331 | 106 789 611 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 800 | 2 465 461 | 0,40 | 43,36 | 424 928 | 106 902 389 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 14 511 | 2 455 661 | 0,59 | 43,38 | 629 415 | 106 514 296 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 400 | 2 441 150 | 0,06 | 43,32 | 60 655 | 105 762 824 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 423 | 2 439 750 | 0,22 | 43,34 | 235 006 | 105 726 566 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 434 327 | 0,01 | 43,37 | 13 012 | 105 582 848 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 747 | 2 434 027 | 0,03 | 43,25 | 32 308 | 105 271 668 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 433 280 | 0,00 | 43,26 | 4 326 | 105 275 859 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 900 | 2 433 180 | 0,04 | 43,24 | 38 912 | 105 198 537 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 300 | 2 432 280 | 0,05 | 43,22 | 56 192 | 105 135 303 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 500 | 2 430 980 | 0,10 | 43,30 | 108 262 | 105 273 589 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 300 | 2 428 480 | 0,18 | 43,32 | 186 276 | 105 201 754 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 800 | 2 424 180 | 0,12 | 43,39 | 121 492 | 105 185 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 421 380 | 0,00 | 43,35 | 4 335 | 104 972 876 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 4 200 | 2 421 280 | 0,17 | 43,29 | 181 818 | 104 817 211 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 600 | 2 417 080 | 0,07 | 43,40 | 69 440 | 104 901 272 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 415 480 | 0,01 | 43,32 | 12 994 | 104 626 516 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 224 | 2 415 180 | 0,09 | 43,23 | 96 144 | 104 408 231 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 217 | 2 412 956 | 0,13 | 43,12 | 138 733 | 104 058 728 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 18 961 | 2 409 739 | 0,79 | 43,28 | 820 632 | 104 293 504 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 575 | 2 390 778 | 0,32 | 43,22 | 327 354 | 103 317 471 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 875 | 2 383 203 | 0,33 | 43,20 | 340 161 | 102 942 454 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 15 775 | 2 375 328 | 0,67 | 43,20 | 681 480 | 102 614 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 200 | 2 359 553 | 0,14 | 43,31 | 138 592 | 102 192 240 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 131 | 2 356 353 | 0,22 | 43,14 | 221 326 | 101 641 287 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 656 | 2 351 222 | 0,03 | 43,34 | 28 431 | 101 901 961 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 5 800 | 2 350 566 | 0,25 | 43,08 | 249 835 | 101 250 630 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 952 | 2 344 766 | 0,17 | 43,17 | 170 608 | 101 223 548 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 237 | 2 340 814 | 0,01 | 43,33 | 10 269 | 101 427 471 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 601 | 2 340 577 | 0,41 | 43,08 | 413 659 | 100 843 760 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 719 | 2 330 976 | 0,29 | 43,28 | 290 832 | 100 896 296 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 701 | 2 324 257 | 0,42 | 43,30 | 420 005 | 100 628 707 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 53 392 | 2 314 556 | 2,36 | 43,10 | 2 301 195 | 99 757 364 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 900 | 2 261 164 | 0,35 | 43,21 | 341 359 | 97 704 896 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 253 264 | 0,01 | 43,23 | 8 646 | 97 414 236 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −550 000 | 0 | −100,00 | 25,25 | −13 885 355 | ||
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 253 064 | 0,00 | 43,17 | 4 317 | 97 270 406 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 499 | 2 252 964 | 0,47 | 43,10 | 452 559 | 97 114 013 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 23 598 | 2 242 465 | 1,06 | 43,28 | 1 021 203 | 97 042 673 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 14 802 | 2 218 867 | 0,67 | 43,26 | 640 335 | 95 988 186 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 575 | 2 204 065 | 0,30 | 43,24 | 284 336 | 95 314 791 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 25 400 | 2 197 490 | 1,17 | 43,09 | 1 094 486 | 94 689 844 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 10 300 | 2 172 090 | 0,48 | 43,07 | 443 621 | 93 551 916 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 200 | 2 161 790 | 0,01 | 43,34 | 8 667 | 93 681 170 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 161 590 | 0,00 | 43,27 | 4 327 | 93 537 403 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 6 758 | 2 161 490 | 0,31 | 43,25 | 292 284 | 93 484 442 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 198 | 2 154 732 | 0,43 | 43,26 | 397 951 | 93 224 480 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 9 100 | 2 145 534 | 0,43 | 43,24 | 393 438 | 92 762 162 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 136 434 | 0,00 | 43,15 | 4 315 | 92 192 468 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 504 | 2 136 334 | 0,16 | 43,22 | 151 460 | 92 343 037 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 080 | 2 132 830 | 0,33 | 43,18 | 305 714 | 92 095 599 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 900 | 2 125 750 | 0,09 | 43,12 | 81 918 | 91 651 711 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 100 | 2 123 850 | 0,00 | 43,32 | 4 332 | 92 005 182 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 8 700 | 2 123 750 | 0,41 | 43,15 | 375 405 | 91 639 812 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 2 100 | 2 115 050 | 0,10 | 43,16 | 90 636 | 91 285 558 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 1 800 | 2 112 950 | 0,09 | 43,18 | 77 733 | 91 247 746 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 220 | 2 111 150 | 0,15 | 43,14 | 138 927 | 91 085 567 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 12 600 | 2 107 930 | 0,60 | 43,19 | 544 194 | 91 041 497 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 35 664 | 2 095 330 | 1,73 | 43,08 | 1 536 405 | 90 266 816 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 800 | 2 059 666 | 0,18 | 43,24 | 164 312 | 89 059 958 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 300 | 2 055 866 | 0,01 | 43,06 | 12 920 | 88 535 869 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 7 300 | 2 055 566 | 0,36 | 43,14 | 314 922 | 88 677 117 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 20 602 | 2 048 266 | 1,02 | 43,22 | 890 418 | 88 526 057 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 13 500 | 2 027 664 | 0,67 | 43,29 | 584 415 | 87 777 575 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
P - Purchase | 3 647 | 2 014 164 | 0,18 | 43,16 | 157 386 | 86 921 247 | |
2016-07-27 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 550 000 | 2 010 517 | 37,66 | 25,25 | 13 885 355 | 50 757 713 | |
2016-07-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 567 | 5 095 | 12,52 | 74,91 | 42 474 | 381 666 | |
2016-04-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 554 | 4 479 | 14,11 | 76,69 | 42 486 | 343 495 | |
2016-03-09 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 672 | 5 977 | 38,84 | ||||
2016-03-03 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −653 | 4 305 | −13,17 | 69,07 | −45 103 | 297 346 | |
2016-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −70 354 | 1 460 517 | −4,60 | 39,52 | −2 780 390 | 57 719 632 | |
2016-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 1 198 630 | 1 198 630 | |||||
2016-02-23 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 136 718 | 1 530 871 | 9,81 | ||||
2016-01-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 310 | 3 880 | 8,68 | 68,52 | 21 241 | 265 858 | |
2016-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 185 | 10 772 | 12,36 | 118,14 | 140 001 | 1 272 569 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −438 000 | 0 | −100,00 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 900 | 1 394 153 | −0,14 | 46,05 | −87 495 | 64 200 746 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 396 053 | −0,02 | 46,04 | −13 814 | 64 281 260 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 396 353 | −0,09 | 46,04 | −59 852 | 64 288 092 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 100 | 1 397 653 | −0,08 | 46,04 | −50 638 | 64 340 956 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 439 | 1 398 753 | −1,02 | 46,03 | −664 627 | 64 384 601 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 413 192 | −0,01 | 46,03 | −9 206 | 65 045 695 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 617 | 1 413 392 | −0,18 | 46,02 | −120 447 | 65 051 367 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 150 | 1 416 009 | −0,85 | 46,02 | −559 143 | 65 164 734 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 921 | 1 428 159 | −0,20 | 46,02 | −134 410 | 65 716 736 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −89 114 | 1 431 080 | −5,86 | 46,01 | −4 100 135 | 65 843 991 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 520 194 | −0,03 | 46,01 | −18 403 | 69 940 325 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 781 | 1 520 594 | −0,96 | 46,00 | −680 000 | 69 954 927 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −296 778 | 1 535 375 | −16,20 | 46,00 | −13 651 788 | 70 627 250 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 438 000 | 1 832 153 | 31,42 | 21,22 | 9 294 097 | 38 877 187 | |
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 280 | 8 832 | 3,27 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 175 | 8 818 | 2,02 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −630 | 0 | −100,00 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 300 | 8 552 | 3,64 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 300 | 8 552 | 3,64 | ||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 630 | 630 | |||||
2015-12-18 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −76 280 | 1 394 153 | −5,19 | ||||
2015-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 327 | 3 531 | 10,21 | 64,90 | 21 222 | 229 162 | |
2015-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 248 | 3 172 | 8,48 | 85,53 | 21 211 | 271 301 | |
2015-04-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 176 | 2 900 | 6,46 | 80,23 | 14 120 | 232 667 | |
2015-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −563 | 4 958 | −10,20 | ||||
2015-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 506 | 5 521 | 37,51 | ||||
2015-03-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −75 630 | 1 470 433 | −4,89 | 47,61 | −3 600 744 | 70 007 315 | |
2015-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 937 031 | 937 031 | |||||
2015-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 132 978 | 1 546 063 | 9,41 | ||||
2015-02-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 88 | 2 702 | 3,37 | 80,12 | 7 051 | 216 484 | |
2015-01-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 77 | 2 614 | 3,04 | 92,51 | 7 123 | 241 821 | |
2015-01-05 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 494 | 9 268 | 19,22 | 93,70 | 140 000 | 868 379 | |
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 185 | 8 252 | 2,29 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 185 | 35 316 | 0,53 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −555 | 0 | −100,00 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 555 | 555 | |||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 295 | 8 067 | 3,80 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 295 | 8 067 | 3,80 | ||||
2014-12-19 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 440 | 1 413 085 | −0,10 | ||||
2014-12-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 2 537 | 2,80 | 102,36 | 7 063 | 259 700 | |
2014-11-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 2 451 | 2,94 | 101,60 | 7 112 | 249 034 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −38 034 | 0 | −100,00 | ||||
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −38 034 | 1 414 525 | −2,62 | 42,70 | −1 624 052 | 60 400 218 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 38 034 | 1 452 559 | 2,69 | 22,27 | 846 903 | 32 344 131 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −402 766 | 35 876 | −91,82 | ||||
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −384 107 | 1 414 525 | −21,36 | 42,50 | −16 324 548 | 60 117 312 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 700 | 1 798 632 | −0,32 | 42,50 | −242 264 | 76 446 357 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 959 | 1 804 332 | −0,71 | 42,50 | −550 822 | 76 693 132 | |
2014-10-30 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 402 766 | 1 817 291 | 28,47 | 22,27 | 8 968 391 | 40 465 619 | |
2014-10-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 71 | 2 381 | 3,07 | 99,45 | 7 061 | 236 790 | |
2014-09-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 65 | 2 310 | 2,90 | 108,68 | 7 064 | 251 039 | |
2014-08-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 2 231 | 3,24 | ||||
2014-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 65 | 2 161 | 3,10 | ||||
2014-06-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 2 096 | 3,40 | ||||
2014-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 67 | 2 015 | 3,44 | ||||
2014-04-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 70 | 1 948 | 3,73 | ||||
2014-03-05 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −498 | 4 015 | −11,03 | 96,31 | −47 962 | 386 685 | |
2014-03-04 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 298 | 4 513 | 40,37 | ||||
2014-03-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 1 878 | 4,04 | ||||
2014-03-04 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −91 882 | 1 414 525 | −6,10 | 39,79 | −3 655 985 | 56 283 950 | |
2014-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 727 699 | 727 699 | |||||
2014-02-25 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 118 865 | 1 506 407 | 8,57 | ||||
2014-02-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 76 | 1 794 | 4,42 | ||||
2014-01-16 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 443 | 7 511 | 23,78 | 97,03 | 140 000 | 728 751 | |
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 220 | 7 772 | 2,91 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 220 | 7 772 | 2,91 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −660 | 0 | −100,00 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 660 | 660 | |||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 350 | 7 552 | 4,86 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 350 | 7 552 | 4,86 | ||||
2014-01-03 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −1 710 | 1 387 542 | −0,12 | ||||
2014-01-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 69 | 1 718 | 4,18 | ||||
2013-12-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 1 649 | 4,70 | ||||
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 389 252 | −0,04 | 38,36 | −23 016 | 53 291 707 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 000 | 1 389 852 | −0,07 | 38,35 | −38 350 | 53 300 824 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 390 852 | −0,20 | 38,34 | −107 352 | 53 325 266 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 393 652 | −0,01 | 38,31 | −3 831 | 53 390 808 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 393 752 | −0,02 | 38,30 | −11 492 | 53 387 670 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 394 052 | −0,02 | 38,30 | −11 490 | 53 392 192 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 183 | 1 394 352 | −0,23 | 38,29 | −121 877 | 53 389 738 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 888 | 1 397 535 | −0,70 | 38,27 | −378 414 | 53 483 664 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 100 | 1 407 423 | −0,29 | 38,26 | −156 886 | 53 855 041 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −48 095 | 1 411 523 | −3,30 | 38,26 | −1 840 115 | 54 004 870 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −54 900 | 1 459 618 | −3,62 | 38,26 | −2 100 200 | 55 837 687 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 400 | 1 514 518 | −0,55 | 38,25 | −321 300 | 57 930 314 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −11 200 | 1 522 918 | −0,73 | 38,24 | −428 344 | 58 243 999 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 108 | 1 534 118 | −0,14 | 38,23 | −80 589 | 58 649 331 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 536 226 | −0,04 | 38,22 | −22 935 | 58 722 239 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 536 826 | −0,15 | 38,22 | −87 906 | 58 737 490 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −300 401 | 0 | −100,00 | ||||
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 500 | 1 539 126 | −0,16 | 38,22 | −95 538 | 58 817 700 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 907 | 1 541 626 | −0,38 | 38,21 | −225 706 | 58 905 529 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 200 | 1 547 533 | −0,27 | 38,20 | −160 461 | 59 123 498 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 800 | 1 551 733 | −0,44 | 38,20 | −259 760 | 59 276 201 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 558 533 | −0,08 | 38,20 | −49 654 | 59 528 168 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 510 | 1 559 833 | −0,29 | 38,19 | −172 237 | 59 570 022 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 564 343 | −0,04 | 38,18 | −26 730 | 59 734 437 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 565 043 | −0,18 | 38,18 | −106 904 | 59 753 342 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 500 | 1 567 843 | −0,10 | 38,16 | −57 240 | 59 828 889 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 400 | 1 569 343 | −0,34 | 38,16 | −206 037 | 59 878 282 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 147 | 1 574 743 | −0,51 | 38,15 | −310 808 | 60 076 445 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 100 | 1 582 890 | −0,57 | 38,14 | −347 120 | 60 379 339 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 1 591 990 | −0,39 | 38,14 | −236 468 | 60 718 499 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 000 | 1 598 190 | −0,12 | 38,14 | −76 270 | 60 946 976 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 600 190 | −0,01 | 38,13 | −7 626 | 61 015 245 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 800 | 1 600 390 | −0,30 | 38,12 | −183 000 | 61 014 869 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 100 | 1 605 190 | −0,19 | 38,12 | −118 172 | 61 189 843 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 800 | 1 608 290 | −0,30 | 38,12 | −182 952 | 61 299 973 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −9 100 | 1 613 090 | −0,56 | 38,10 | −346 756 | 61 466 794 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 763 | 1 622 190 | −0,84 | 38,10 | −524 370 | 61 805 439 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 200 | 1 635 953 | −0,13 | 38,10 | −83 809 | 62 321 630 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 300 | 1 638 153 | −0,26 | 38,09 | −163 787 | 62 397 248 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 642 453 | −0,04 | 38,09 | −26 661 | 62 556 929 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 400 | 1 643 153 | −0,15 | 38,08 | −91 404 | 62 579 482 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 200 | 1 645 553 | −0,62 | 38,08 | −388 416 | 62 662 658 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −10 300 | 1 655 753 | −0,62 | 38,08 | −392 172 | 63 042 795 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −12 000 | 1 666 053 | −0,72 | 38,07 | −456 840 | 63 426 638 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 800 | 1 678 053 | −0,52 | 38,06 | −334 972 | 63 875 087 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 800 | 1 686 853 | −0,17 | 38,06 | −106 568 | 64 201 625 | |
2013-11-26 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 300 401 | 1 689 653 | 21,62 | 33,37 | 10 024 381 | 56 383 721 | |
2013-11-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 565 | 5,03 | ||||
2013-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 490 | 5,30 | ||||
2013-09-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 76 | 1 415 | 5,68 | ||||
2013-08-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 329 | 5,98 | ||||
2013-07-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 1 254 | 6,36 | ||||
2013-06-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 72 | 1 179 | 6,50 | ||||
2013-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 1 100 | 7,21 | ||||
2013-04-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 72 | 1 026 | 7,55 | ||||
2013-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
F - Taxes | −406 | 3 215 | −11,21 | 90,64 | −36 798 | 291 392 | |
2013-03-06 |
|
4 | CAT |
CATERPILLAR INC
Common Stock |
A - Award | 1 115 | 3 621 | 44,49 | ||||
2013-03-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 67 | 954 | 7,55 | ||||
2013-03-01 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −90 318 | 1 389 252 | −6,10 | 34,26 | −3 094 295 | 47 595 774 | |
2013-02-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 980 000 | 980 000 | |||||
2013-02-20 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 210 000 | 1 479 570 | 16,54 | ||||
2013-02-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 64 | 887 | 7,78 | ||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 300 401 | 300 401 | |||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −346 704 | 0 | −100,00 | ||||
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −300 401 | 1 269 570 | −19,13 | 33,37 | −10 024 381 | 42 365 551 | |
2013-01-16 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 346 704 | 1 569 971 | 28,34 | 25,76 | 8 929 535 | 40 435 388 | |
2013-01-03 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 587 | 5 878 | 36,99 | 88,21 | 140 000 | 518 509 | |
2013-01-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 71 | 823 | 9,44 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 366 | 7 202 | 5,35 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −183 | 0 | −100,00 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −183 | 0 | −100,00 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −385 | 1 223 450 | −0,03 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 366 | 7 293 | 5,28 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −366 | 183 | −66,67 | ||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | 549 | 549 | |||||
2012-12-28 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −15 921 | 1 223 835 | −1,28 | ||||
2012-12-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 77 | 748 | 11,48 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 239 756 | −0,05 | 65,88 | −39 528 | 81 675 125 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 240 356 | −0,02 | 65,83 | −13 166 | 81 652 635 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 1 240 556 | −0,11 | 65,82 | −92 148 | 81 653 396 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 241 956 | −0,01 | 65,82 | −6 582 | 81 739 334 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 300 | 1 242 056 | −0,10 | 65,81 | −85 553 | 81 739 705 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 243 356 | −0,02 | 65,80 | −13 160 | 81 812 825 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 357 | 1 243 556 | −1,06 | 65,78 | −878 623 | 81 801 114 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −747 | 1 256 913 | −0,06 | 65,77 | −49 130 | 82 667 168 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −153 | 1 257 660 | −0,01 | 65,76 | −10 061 | 82 703 722 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −600 | 1 257 813 | −0,05 | 65,75 | −39 450 | 82 701 205 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 197 | 1 258 413 | −0,10 | 65,74 | −78 691 | 82 728 071 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 259 610 | −0,06 | 65,73 | −46 011 | 82 794 165 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 400 | 1 260 310 | −0,11 | 65,72 | −92 008 | 82 827 573 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 600 | 1 261 710 | −0,28 | 65,71 | −236 556 | 82 906 964 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 265 310 | −0,02 | 65,70 | −19 710 | 83 130 867 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 1 265 610 | −0,04 | 65,68 | −32 840 | 83 125 265 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 266 110 | −0,01 | 65,67 | −6 567 | 83 145 444 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 280 | 1 266 210 | −0,10 | 65,66 | −84 045 | 83 139 349 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 822 | 1 267 490 | −0,14 | 65,65 | −119 614 | 83 210 718 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 269 312 | −0,02 | 65,64 | −13 129 | 83 323 986 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 518 | 1 269 512 | −0,51 | 65,64 | −427 842 | 83 330 768 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 1 276 030 | −0,04 | 65,64 | −32 818 | 83 752 229 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −14 592 | 1 276 530 | −1,13 | 65,63 | −957 673 | 83 778 664 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 291 122 | −0,02 | 65,63 | −19 688 | 84 731 172 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 291 422 | −0,18 | 65,62 | −150 938 | 84 749 569 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −21 156 | 1 293 722 | −1,61 | 65,62 | −1 388 257 | 84 894 038 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 314 878 | −0,01 | 65,62 | −6 562 | 86 279 665 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 314 978 | −0,01 | 65,62 | −6 562 | 86 285 569 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −4 600 | 1 315 078 | −0,35 | 65,62 | −301 829 | 86 288 843 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −15 103 | 1 319 678 | −1,13 | 65,61 | −990 908 | 86 584 074 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 239 | 1 334 781 | −0,09 | 65,60 | −81 285 | 87 568 308 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 982 | 1 336 020 | −0,67 | 65,60 | −589 219 | 87 642 912 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −1 924 | 1 345 002 | −0,14 | 65,60 | −126 205 | 88 225 406 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −25 718 | 1 346 926 | −1,87 | 65,59 | −1 686 844 | 88 344 876 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 372 644 | −0,01 | 65,59 | −6 559 | 90 030 347 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 372 744 | −0,03 | 65,59 | −26 235 | 90 035 533 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 200 | 1 373 144 | −0,45 | 65,58 | −406 627 | 90 057 649 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −178 002 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −1 890 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −262 464 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −70 956 | 0 | −100,00 | ||||
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 379 344 | −0,01 | 65,58 | −6 558 | 90 462 897 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 500 | 1 379 444 | −0,47 | 65,58 | −426 270 | 90 463 938 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −2 300 | 1 385 944 | −0,17 | 65,58 | −150 822 | 90 883 278 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −18 246 | 1 388 244 | −1,30 | 65,57 | −1 196 390 | 91 027 159 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −13 952 | 1 406 490 | −0,98 | 65,56 | −914 693 | 92 209 484 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −3 651 | 1 420 442 | −0,26 | 65,56 | −239 341 | 93 117 075 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −31 069 | 1 424 093 | −2,14 | 65,55 | −2 036 573 | 93 349 296 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 455 162 | −0,01 | 65,55 | −6 555 | 95 384 414 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 455 262 | −0,02 | 65,55 | −19 664 | 95 388 786 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 600 | 1 455 562 | −0,45 | 65,54 | −432 597 | 95 404 811 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −31 032 | 1 462 162 | −2,08 | 65,54 | −2 033 837 | 95 830 097 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 493 194 | −0,02 | 65,54 | −19 662 | 97 862 442 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 493 494 | −0,01 | 65,54 | −6 554 | 97 879 863 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 1 493 594 | −0,01 | 65,54 | −6 554 | 97 885 670 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 300 | 1 493 694 | −0,42 | 65,54 | −412 870 | 97 889 236 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −34 230 | 1 499 994 | −2,23 | 65,53 | −2 243 092 | 98 294 607 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −700 | 1 534 224 | −0,05 | 65,53 | −45 870 | 100 536 164 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 1 534 924 | −0,01 | 65,53 | −13 106 | 100 579 732 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −7 500 | 1 535 124 | −0,49 | 65,52 | −491 438 | 100 589 000 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −35 920 | 1 542 624 | −2,28 | 65,52 | −2 353 478 | 101 072 724 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −400 | 1 578 544 | −0,03 | 65,52 | −26 207 | 103 422 257 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 900 | 1 578 944 | −0,44 | 65,52 | −452 054 | 103 444 516 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −39 418 | 1 585 844 | −2,43 | 65,51 | −2 582 273 | 103 888 640 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 1 625 262 | −0,02 | 65,51 | −19 653 | 106 469 288 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 326 | 1 625 562 | −0,51 | 65,50 | −545 395 | 106 482 439 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −119 180 | 1 633 888 | −6,80 | 65,50 | −7 806 290 | 107 019 664 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 178 002 | 1 753 068 | 11,30 | 59,03 | 10 507 458 | 103 483 604 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 1 890 | 1 575 066 | 0,12 | 53,60 | 101 304 | 84 423 538 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 262 464 | 1 573 176 | 20,02 | 52,55 | 13 792 483 | 82 670 399 | |
2012-11-05 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 70 956 | 1 310 712 | 5,72 | 47,10 | 3 342 028 | 61 734 535 | |
2012-11-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 671 | 12,21 | ||||
2012-10-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 598 | 13,90 | ||||
2012-09-05 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 75 | 525 | 16,67 | ||||
2012-08-01 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 450 | 19,36 | ||||
2012-07-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 74 | 377 | 24,42 | ||||
2012-06-04 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 73 | 303 | 31,74 | ||||
2012-05-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 61 | 230 | 36,09 | ||||
2012-04-03 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 59 | 169 | 53,64 | ||||
2012-03-09 |
|
4 | CAT |
CATERPILLAR INC
Common |
F - Taxes | −392 | 2 497 | −13,57 | 107,47 | −42 128 | 268 353 | |
2012-03-07 |
|
4 | CAT |
CATERPILLAR INC
Common |
A - Award | 909 | 2 889 | 45,91 | ||||
2012-03-02 |
|
4 | CAT |
CATERPILLAR INC
Phantom Stock Units |
A - Award | 54 | 110 | 96,43 | ||||
2012-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −88 360 | 1 239 756 | −6,65 | 57,04 | −5 040 054 | 70 715 682 | |
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 302 500 | 302 500 | |||||
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 167 600 | 1 328 116 | 14,44 | ||||
2012-02-01 |
|
4 | CAT |
CATERPILLAR INC
Common |
A - Award | 56 | 56 | |||||
2012-01-04 |
|
4 | MCD |
MCDONALDS CORP
Phantom Stock |
A - Award | 1 296 | 4 161 | 45,23 | 100,33 | 130 000 | 417 441 | |
2009-05-14 |
|
4 | MCD |
MCDONALDS CORP
Common Stock |
P - Purchase | 5 000 | 5 000 | 53,97 | 269 850 | 269 850 | ||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −8 390 | 762 300 | −1,09 | 44,15 | −370 418 | 33 655 545 | |
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 438 000 | 438 000 | |||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 139 000 | 770 690 | 22,00 | 44,16 | 6 138 240 | 34 033 670 | |
2005-10-04 | 3 | MOT |
MOTOROLA INC
Motorola, Inc. - Common Stock |
2 000 |